Santa Ana Therapeutics
PrivateLast Round
Series B
Jun 13, 2024
Est. Valuation
$270M
Total Funding Raised
$168M
Company Overview
Santa Ana Therapeutics is a biotechnology company developing precision medicines for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santa Ana Therapeutics Comparables
Compare Santa Ana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirador Therapeutics | 87% | |
| Seismic | 83% | |
| UCB | 82% |
Santa Ana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2024 | ||||
| Series A | Jun 13, 2024 |
Santa Ana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| GV | Series A, Series B |
| Versant Ventures | Series B, Series A |
| RTW Investments | Series B |
| Access Biotechnology | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 13, 2024
$125M round led by GV
Santa Ana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Santa Ana Therapeutics's valuation, stock price, and market status.
Is Santa Ana Therapeutics a public or private company?
Santa Ana Therapeutics is a private company.
What is the current stock price of Santa Ana Therapeutics?
Santa Ana Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Santa Ana Therapeutics worth (valuation)?
Santa Ana Therapeutics's valuation is estimated at $270.0M based on funding round data.
Can I buy Santa Ana Therapeutics stock?
Santa Ana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Santa Ana Therapeutics's last funding round?
Santa Ana Therapeutics's most recent funding round was Series B on June 13, 2024.
Who are the main investors in Santa Ana Therapeutics?
Key investors in Santa Ana Therapeutics include GV, Versant Ventures.
Will Santa Ana Therapeutics IPO soon?
No public IPO plans have been announced for Santa Ana Therapeutics.
How can I track Santa Ana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Santa Ana Therapeutics's secondary market activity and sign up for updates.